SST

Gene Information
 
Gene Symbol
SST
 
Aliases
SMST
 
Entrez Gene ID
 
Gene Name
Somatostatin
 
Chromosomal Location
3q27.3
 
HGNC ID
 
Summary
The hormone somatostatin has active 14 aa and 28 aa forms that are produced by alternate cleavage of the single preproprotein encoded by this gene. Somatostatin is expressed throughout the body and inhibits the release of numerous secondary hormones by binding to high-affinity G-protein-coupled somatostatin receptors. This hormone is an important regulator of the endocrine system through its interactions with pituitary growth hormone, thyroid stimulating hormone, and most hormones of the gastrointestinal tract. Somatostatin also affects rates of neurotransmission in the central nervous system and proliferation of both normal and tumorigenic cells. [provided by RefSeq, Jul 2008]
  e!Ensembl
Gene
Transcript  
Protein

Gene Ontology (GO)

GO ID Ontology Function Evidence Reference
GO:0007166 Biological process Cell surface receptor signaling pathway TAS 9437026
GO:0007186 Biological process G protein-coupled receptor signaling pathway TAS 8405411
GO:0007267 Biological process Cell-cell signaling TAS 6145156
GO:0007268 Biological process Chemical synaptic transmission TAS 9437026
GO:0007584 Biological process Response to nutrient TAS 6145156
Protein Information
 
Protein Name
Somatostatin, growth hormone release-inhibiting factor, prepro-somatostatin, somatostatin-14, somatostatin-28
 
Function
[Somatostatin-14]: Inhibits the secretion of pituitary hormones, including that of growth hormone/somatotropin (GH1), PRL, ACTH, luteinizing hormone (LH) and TSH. Also impairs ghrelin- and GnRH-stimulated secretion of GH1 and LH; the inhibition of ghrelin-stimulated secretion of GH1 can be further increased by neuronostatin. .; [Neuronostatin]: May enhance low-glucose-induced glucagon release by pancreatic alpha cells (By similarity). This effect may be mediated by binding to GPR107 and PKA activation (By similarity). May regulate cardiac contractile function (By similarity). May compromise cardiomyocyte viability (By similarity). In the central nervous system, may impair memory retention and may affect hippocampal excitability (By similarity). May also have anxiolytic and anorexigenic effects (By similarity). May play a role in arterial pressure regulation (By similarity). May inhibit basal, but not ghrelin- or GnRH-stimulated secretion of GH1 or LH, but does not affect the release of other pituitary hormones, including PRL, ACTH, FSH or TSH. Potentiates inhibitory action of somatostatin on ghrelin-stimulated secretion of GH1, but not that on GnRH-stimulated secretion of LH (PubMed:29615476).
 
UniProt
 
PDB
 
Pfam
Pfam Accession Pfam ID
PF03002 Somatostatin
Pathways
 
KEGG
 
Reactome
 

cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gastric acid secretion

 

Peptide ligand-binding receptors
G alpha (i) signalling events

Interactions
 
STRING MINT IntAct
ENSP00000349960 P60709 P60709
    View interactions
     

Associated Diseases

Disease groupDisease NameReferences
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Atonic seizures
Digestive System Diseases
Gastric Varix
Esophageal Varices
Pancreatitis
Endocrine System Diseases
PCOS
References
 
 
PubMed ID Associated gene/s Associated condition Genetic Mutation Diagnostic Criteria Association with PCOS Ethnicity Conclusion
beta-EP, Dyn A  
PCOS 
 
 
Related 
Group 1 (LH/ FSH > or = 3, n = 30); group 2 (LH/FSH < 3, n = 25), and controls (n = 15) 
The data suggest endogenously lower SS, higher beta-EP and Dyn A may contribute to the elevation of LH and insulin secretions in PCOS. 
beta-EP, Dyn A  
PCOS 
 
 
Related 
15 normally menstruating women (control) and 30 PCOS women with LH/follicle stimulating hormone (FSH) ratio greater than 3 (group 1) and 25 PCOS subjects with the ratio < 3 (group 2) 
These data suggested lower endogenous SS, higher beta-EP and Dyn A may lead to elevation of LH and insulin secretions in patients with PCOS. 

| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412